VERAXA Biotech GmbH

Contributing Author

Recent Articles by VERAXA Biotech GmbH

Jul-10	VERAXA Biotech AG Appoints Carl von Halem as Interim Chief Financial Officer and Successor to Torsten Burgermeister VRXA -11.29% GlobeNewswire
Jul-06	VERAXA Biotech Provides Business Update and Further Details on Partnering Strategy and Development Timelines VRXA +7.35% GlobeNewswire
Jul-02	VERAXA Biotech Initiates Cell Line Development with ATUM to Advance its Lead BiTAC-TCE Program VRXA +18.26% GlobeNewswire
Jun-24	VERAXA Biotech Expands R&D Hub in Heidelberg as Innovative BiTAC-TCE and ADC Programs Advance Towards Clinical Development VRXA -20.96% GlobeNewswire
Jun-18	VERAXA Biotech Establishes in vitro Proof-of-Concept for Novel BiTAC-ADC Technology Platform and Launches Partnering Discussions at BIO International Convention 2026 VRXA -23.55% GlobeNewswire